A detailed history of Causeway Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Causeway Capital Management LLC holds 695,979 shares of NVO stock, worth $33.7 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
695,979
Previous 353,884 96.67%
Holding current value
$33.7 Million
Previous $24.4 Million 58.11%
% of portfolio
0.7%
Previous 0.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$45.38 - $71.7 $15.5 Million - $24.5 Million
342,095 Added 96.67%
695,979 $38.6 Million
Q2 2025

Aug 13, 2025

BUY
$58.08 - $81.05 $20.6 Million - $28.7 Million
353,884 New
353,884 $24.4 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Causeway Capital Management LLC Portfolio

Follow Causeway Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Causeway Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Causeway Capital Management LLC with notifications on news.